Status:
TERMINATED
OAB and the Microbiome
Lead Sponsor:
University of Miami
Conditions:
Overactive Bladder
Urgency-frequency Syndrome
Eligibility:
FEMALE
18-90 years
Brief Summary
To determine differences in the urinary microbiomes, identified by polymerase change reaction (PCR) (UTIP™), of female patients with urgency and frequency syndrome with or without pelvic pain (Group A...
Eligibility Criteria
Inclusion
- 18 y/o-90 y/o
- Able to consent
- Group A only: Urgency and Frequency Syndrome or OAB only. UDI-6 answer of "moderately" to "quite a bit" on questions 1 or 2.
- Group B only: Urinary Distress Inventory 6 (UDI-6) answer "not at all" or "somewhat" for questions 1 or 2.
Exclusion
- Pregnant
- Pelvic radiation
- Urinary retention (\>200 ml)
- Renal calculi
- Recurrent urinary tract infection (UTI) (2 in 6 months), or
- Current UTI
- Immunosuppressed or radiation history
- Neurologic disorder
Key Trial Info
Start Date :
June 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 20 2023
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT04831801
Start Date
June 30 2021
End Date
November 20 2023
Last Update
May 21 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Holy Cross Hospital
Fort Lauderdale, Florida, United States, 33301
2
University of Miami
Miami, Florida, United States, 33136